E. Stefanski

915 total citations
27 papers, 797 citations indexed

About

E. Stefanski is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, E. Stefanski has authored 27 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in E. Stefanski's work include Bone health and treatments (6 papers), Protease and Inhibitor Mechanisms (5 papers) and Vitamin K Research Studies (4 papers). E. Stefanski is often cited by papers focused on Bone health and treatments (6 papers), Protease and Inhibitor Mechanisms (5 papers) and Vitamin K Research Studies (4 papers). E. Stefanski collaborates with scholars based in Canada, United States and Sweden. E. Stefanski's co-authors include Peter Vadas, W. Pruzanski, Murray B. Urowitz, Frederick C. de Beer, M C de Beer, Kieran F. Scott, Amir Ravandi, A. Kuksis, I A Rajkovic and G. L. Smith and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical Journal and Journal of Lipid Research.

In The Last Decade

E. Stefanski

26 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Stefanski Canada	16	396	135	131	117	95	27	797
Eva Stefanski Canada	19	474 1.2×	150 1.1×	141 1.1×	179 1.5×	193 2.0×	24	1.1k
Deborah A. Rathjen Australia	17	352 0.9×	57 0.4×	63 0.5×	313 2.7×	74 0.8×	40	900
Rebecca Mar United States	7	270 0.7×	215 1.6×	272 2.1×	261 2.2×	71 0.7×	7	984
Sreekant Murthy United States	9	547 1.4×	144 1.1×	176 1.3×	202 1.7×	157 1.7×	29	962
B. Moseley Waite United States	16	337 0.9×	39 0.3×	100 0.8×	198 1.7×	83 0.9×	28	909
Norman A. Granholm United States	17	281 0.7×	60 0.4×	278 2.1×	233 2.0×	32 0.3×	34	918
Edward J. Sarcione United States	19	415 1.0×	88 0.7×	117 0.9×	72 0.6×	34 0.4×	47	957
Violetta D. Dadufalza United States	12	165 0.4×	208 1.5×	163 1.2×	113 1.0×	33 0.3×	18	611
Sally M. Fuerstenberg Sweden	8	505 1.3×	71 0.5×	104 0.8×	199 1.7×	30 0.3×	9	1.2k
Scott Thomson United Kingdom	11	482 1.2×	119 0.9×	40 0.3×	220 1.9×	46 0.5×	13	1.0k

Countries citing papers authored by E. Stefanski

Since Specialization

Citations

This map shows the geographic impact of E. Stefanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Stefanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Stefanski more than expected).

Fields of papers citing papers by E. Stefanski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Stefanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Stefanski. The network helps show where E. Stefanski may publish in the future.

Co-authorship network of co-authors of E. Stefanski

This figure shows the co-authorship network connecting the top 25 collaborators of E. Stefanski. A scholar is included among the top collaborators of E. Stefanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Stefanski. E. Stefanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stefanski, E., et al.. (2024). Limb length restoring through novel limb salvage procedure via ipsilateral fibular strut autograft: A case report. SHILAP Revista de lepidopterología. 4(4). 100422–100422. 1 indexed citations

Pruzanski, W., et al.. (1998). Chemically modified non-antimicrobial tetracyclines inhibit activity of phospholipases A2.. PubMed. 25(9). 1807–12. 31 indexed citations

Pruzanski, W., E. Stefanski, & Peter Vadas. (1996). Inhibition of the activity of pro‐inflammatory secretory phospholipase A₂ by acute phase proteins. Mediators of Inflammation. 5(3). 196–201. 1 indexed citations

Pruzanski, W., Brian P. Kennedy, H. van den Bosch, et al.. (1995). Tenidap sodium inhibits secretory non‐pancreatic phospholipase A₂ synthesis by foetal rat calvarial osteoblasts. Mediators of Inflammation. 4(1). 67–70. 3 indexed citations

Pruzanski, W., Frederick C. de Beer, M C de Beer, E. Stefanski, & Peter Vadas. (1995). Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. Biochemical Journal. 309(2). 461–464. 59 indexed citations

Vadas, Peter, et al.. (1995). 111 THE EFFECT OF LIPID PEROXIDATION ON HUMAN SECRETORY PHOSPHOLIPASE A2 (sPLA2)-MEDIATED DEGRADATION OF CELL MEMBRANES. Shock. 3(5). 34–34. 1 indexed citations

Pruzanski, W., Earl R. Bogoch, Alan Katz, et al.. (1995). Induction of release of secretory nonpancreatic phospholipase A2 from human articular chondrocytes.. PubMed. 22(11). 2114–9. 13 indexed citations

Pruzanski, W., et al.. (1994). Phospholipase A2 in juvenile rheumatoid arthritis: correlation to disease type and activity.. PubMed. 21(10). 1951–4. 17 indexed citations

Vadas, Peter, Kieran F. Scott, G. L. Smith, et al.. (1992). Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock. Life Sciences. 50(11). 807–811. 54 indexed citations

10.

Pruzanski, W., Kieran F. Scott, G. L. Smith, et al.. (1992). Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids. Inflammation. 16(5). 451–457. 31 indexed citations

11.

Pruzanski, W., Douglas W. Wilmore, A F Suffredini, et al.. (1992). Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin. Inflammation. 16(5). 561–570. 33 indexed citations

12.

Pruzanski, W., Andréas Mackensen, R. Engelhardt, E. Stefanski, & Peter Vadas. (1992). Induction of Circulating Phospholipase A2 Activity by Intravenous Infusion of Endotoxin in Patients with Neoplasia. Journal of Immunotherapy. 12(4). 242–246. 14 indexed citations

13.

Pruzanski, W., et al.. (1990). Hypophospholipasemia A2 in systemic sclerosis.. PubMed. 17(9). 1182–6. 1 indexed citations

14.

Vadas, Peter, W. Pruzanski, E. Stefanski, & Berit Sternby. (1990). Compartmental heterogeneity of soluble phospholipases A. Inflammation. 14(2). 173–183. 10 indexed citations

15.

Pruzanski, W., Earl R. Bogoch, E. Stefanski, Marek Wloch, & Peter Vadas. (1990). Synthesis and release of phospholipase A2 by unstimulated human articular chondrocytes.. PubMed. 17(10). 1386–91. 19 indexed citations

16.

Vadas, Peter, W. Pruzanski, & E. Stefanski. (1988). Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock?. Inflammation Research. 24(3-4). 320–325. 40 indexed citations

17.

Vadas, Peter, W. Pruzanski, E. Stefanski, et al.. (1988). Concordance of endogenous cortisol and phospholipase A2 levels in gram-negative septic shock: a prospective study.. PubMed. 111(5). 584–90. 24 indexed citations

18.

Vadas, Peter, E. Stefanski, & W. Pruzanski. (1986). Influence of plasma proteins on activity of proinflammatory enzyme phospholipase A2. Inflammation. 10(2). 183–193. 28 indexed citations

19.

Vadas, Peter, E. Stefanski, & W. Pruzanski. (1986). Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shock. Inflammation Research. 19(3-4). 194–202. 44 indexed citations

20.

Schwartz, Stephen A., Sandra Panem, E. Stefanski, & W. H. Kirsten. (1974). Endogenous type C particles from rat embryo cells treated with 5-bromodeoxyuridine.. PubMed. 34(9). 2255–9. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact